BioWorld Asia

April 27, 2005

TKT Absorbed For $1.6B As Shire Fattens Pipeline

In what could be the largest acquisition of 2005 - and certainly the largest so far - Shire Pharmaceuticals Group plc has nabbed Transkaryotic Therapies Inc. in a deal worth $1.6 billion. (BioWorld International) Read More

£32.8M For Alizyme Earmarked For Renzapride, Cetilistat Work

Blocking Toxins Could Defeat Bacterial Antibiotic Resistance

Genmab Moves Zanolimumab Into Lymphoma Pivotal Study

Tight Agrobiotech Rulings Provoke German Lawsuit

Cash Squeeze Could Hamper Finnish Personalized Medicine

Microdosing Guidelines From FDA Might Reduce Time, Waste

Europe Pressures Syngenta On Testing, Containing Bt10

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...